@misc{10498/33757,
year = {2024},
url = {http://hdl.handle.net/10498/33757},
abstract = {Lichenoid eruptions (LE) pose a real diagnostic challenge dueto their clinical and histopathological similarity to lichenplanus. Inducers are varied being drug-induced lichenoideruption (DILE) a common entity, particularly in an eracharacterized by the emergence of biologic or targeted ther-apies. This is the case of an alirocumab-induced lichenoideruption, a proprotein convertase subtilisin/kexin type 9(PCSK-9) inhibitor used to treat dyslipidemia, a drug rarelyassociated with local skin adverse reactions and exception-ally with urticaria, or vasculitis.},
publisher = {Elsevier},
keywords = {Alirocumab},
keywords = {lichenoid eruption},
title = {Alirocumab-Associated Lichenoid Reaction: A Case Report},
doi = {10.1016/J.AD.2022.11.022},
author = {Román Cheuque, R. and Navarro Navarro, Irene and Jiménez Gallo, D. and Linares Barrios, Mario Dionisio},
}